A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

NCT00398606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

650

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: MK0217, alendronate sodium / Duration of Treatment : 2 Years
DRUG: Comparator : calcium carbonate /Duration of Treatment : 2 Years

Sponsor

Organon and Co